CTLA4 and lymphedema: To elucidate the transcriptomic features and pathways underlying the protective/therapeutic effect of anti-CTLA4 in lymphedema, we performed bulk RNA sequencing analyses of full-thickness tail skin from anti-CTLA4 treated and control mice.